The latest closing stock price for Elicio Therapeutics as of September 18, 2024 is 5.09.
An investor who bought $1,000 worth of Elicio Therapeutics stock at the IPO in 2021 would have $-701 today, roughly -1 times their original investment - a -26.05% compound annual growth rate over 4 years.
The all-time high Elicio Therapeutics stock closing price was 25.74 on February 22, 2021.
The Elicio Therapeutics 52-week high stock price is 11.45, which is 125% above the current share price.
The Elicio Therapeutics 52-week low stock price is 2.96, which is 41.8% below the current share price.
The average Elicio Therapeutics stock price for the last 52 weeks is 6.20.
An investor who bought $1,000 worth of Elicio Therapeutics stock at the IPO in 2021 would have $-701 today, roughly -1 times their original investment - a -26.05% compound annual growth rate over 4 years.
The all-time high Elicio Therapeutics stock closing price was 25.74 on February 22, 2021.
The Elicio Therapeutics 52-week high stock price is 11.45, which is 125% above the current share price.
The Elicio Therapeutics 52-week low stock price is 2.96, which is 41.8% below the current share price.
The average Elicio Therapeutics stock price for the last 52 weeks is 6.20.